An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who ...

Improvement in QoL, other PROs seen for those who switched to tirzepatide after not achieving glycemic control on stable dose of dulaglutide.

A 4-year study of cataract surgeons found that access to an unmasked peer benchmarking dashboard, supported by a noncoercive, ...

Please provide your email address to receive an email when new articles are posted on . Historically, patient-reported outcome measures were primarily used for research. Today, surgeons use ...

She recently attended the 2026 American Academy of Dermatology Annual Meeting in Denver, where she spoke at several sessions, ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

Please provide your email address to receive an email when new articles are posted on . Use of an electronic patient-reported outcome-based program did not significantly reduce ED or inpatient visits ...

For patients with allergic rhinitis and chronic rhinosinusitis, the addition of vidian neurectomy to endoscopic sinus surgery ...

SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained ...

Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Patients with locally advanced ...

An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in ...